Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
Mifepristone is a promising option for the management of hypercortisolism associated with hyperglycemia. However, its use may result in serious electrolyte imbalances, especially during dose escalation. In our patient with adrenocorticotropic hormone-independent macro-nodular adrenal hyperplasia, un...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2019-11-01
|
| Series: | Endocrinology, Diabetes & Metabolism Case Reports |
| Online Access: | https://doi.org/10.1530/EDM-19-0064 |